Better Tolerance of Citalopram in a Breastfed Infant Who Could Not Tolerate Sertraline and Paroxetine
Author:
- 1 January 2018
- journal article
- case report
- Published by SAGE Publications in Breastfeeding Medicine
- Vol. 13 (1) , 89-90
Abstract
Postpartum depression is frequently observed in women. First-line antidepressants in treatment of postpartum depression are selective serotonin reuptake inhibitors (SSRIs). Although SSRIs are well tolerated by most breastfed infants, some adverse events may arise in exposed infants. This report presents the case of an infant of a breastfeeding woman using citalopram without any problem after sertraline and paroxetine were discontinued due to adverse events in the infant.Keywords
This publication has 12 references indexed in Scilit:
- Serotonin reuptake inhibitors and breastfeeding: a systematic reviewHuman Psychopharmacology: Clinical and Experimental, 2015
- Concise Review for Physicians and Other Clinicians: Postpartum DepressionMayo Clinic Proceedings, 2014
- From the third month of pregnancy to 1 year postpartum. Prevalence, incidence, recurrence, and new onset of depression. Results from the Perinatal Depression–Research & Screening Unit studyComprehensive Psychiatry, 2011
- Postpartum depression: what we knowJournal of Clinical Psychology, 2009
- Importance of a correct initial diagnosis and stabilization to avoid social and economic consequences.The Journal of Clinical Psychiatry, 2007
- Postpartum-onset major depression is associated with personality disordersComprehensive Psychiatry, 2007
- Use of Contemporary Antidepressants during BreastfeedingDrug Safety, 2007
- Multicentre prospective study of perinatal depression in Japan: incidence and correlates of antenatal and postnatal depressionArchives of Women's Mental Health, 2006
- Perinatal DepressionObstetrics & Gynecology, 2005
- Transfer of Risperidone and 9-Hydroxyrisperidone into Human MilkAnnals of Pharmacotherapy, 2004